CERO
CERo Therapeutics Holdings Inc (CERO)
Healthcare • NASDAQ • $0.03+5.98%
Key Fundamentals
- Symbol
- CERO
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $0.03
- Daily Change
- +5.98%
- Market Cap
- $1.21M
- Trailing P/E
- N/A
- Forward P/E
- -0.01
- 52W High
- $26.99
- 52W Low
- $0.02
- Analyst Target
- N/A
- Dividend Yield
- N/A
- Beta
- 0.24
About CERo Therapeutics Holdings Inc
CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.
Company websiteResearch CERO on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.